Market Overview

InspireMD Stock Rallies After Vietnam Approves Embolism Prevention Products

Share:
InspireMD Stock Rallies After Vietnam Approves Embolism Prevention Products
Related NSPR
41 Biggest Movers From Yesterday
30 Stocks Moving In Wednesday's Mid-Day Session
InspireMD's CGuard EPS Featured at the SBHCI Congress in Brazil (GuruFocus)

InspireMD Inc (NYSE: NSPR) stock rallied Monday on news of regulatory approval for its products.

What Happened

InspireMD announced that it received regulatory approval for its CGuard Embolic Prevention System and MGuard Prime in Vietnam. Both of these devices utilize MicroNet technology, and the company has initiated commercialization of products.

Why It's Important

Vietnam has a population of over 100 million and represents an important step in the company's expansion across Asia, Chief Commercial Officer Agustin Gago said in a statement

InspireMD secured a valid import license and product reimbursement from Vietnam's Department of Medical Equipment and Health Works, speeding the products' path to market, the CCO said. 

What's Next

The Israeli company recently appointed DO GIA as its distributor in Vietnam. DO GIA has an established distribution network across Vietnam that covers both physicians, clinics and hospitals, Gago said.

InspireMD Inc sells the CGuard Embolic Prevention System  and MGuard Prime in a variety of markets across Europe, the Middle East, Asia and Latin America.

Price Action

InspireMD shares were set to close up 9.65 percent Monday at $1.25. 

Related Links:

The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap 

FDA Clears New Drug Application For Pluristem's PLX-R18; What's Next? 

Posted-In: CGuard Embolic Prevention System (EPS) MGuard Prime Regulatory approvalNews Health Care Small Cap General Best of Benzinga

 

Related Articles (NSPR)

View Comments and Join the Discussion!